amgen - International Pharmaceutical Industry

HOME
CURRENT
FEATURES
EDITORIAL
ARCHIVES
ARCHIVED
ISSUES
EVENTS
COMPANY
PROFILES
A-D

E-M

N-S

T-Z
SPONSORED
ARTICLES
NEWS
EBOOKS

SCHOTT Pharma
PODCAST
Generic selectors

Exact matches only

Search in title

Search in content

Post Type Selectors

Current Edition

News

New tezepelumab data shows improvements for severe asthma subgroup

AstraZeneca and Amgen’s thymic stromal lymphopoietin (TSLP) blocker tezepelumab has demonstrated new improvements for patients with severe asthma and comorbid nasal ...

8 September 2021 News amgen | AstraZeneca

Continue Reading →

News

Novartis and Amgen Highlight Findings from a Large Global Patient Survey on Migranes

Novartis and Amgen highlight findings from a large global patient survey revealing that worldwide approximately 60% of employed people with migraine missed, on avera...